Mark Sheptoff Financial Planning LLC grew its stake in UnitedHealth Group Inc (NYSE:UNH) by 0.9% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 37,602 shares of the healthcare conglomerate’s stock after acquiring an additional 318 shares during the quarter. UnitedHealth Group comprises about 7.8% of Mark Sheptoff Financial Planning LLC’s portfolio, making the stock its biggest position. Mark Sheptoff Financial Planning LLC’s holdings in UnitedHealth Group were worth $9,367,000 as of its most recent filing with the Securities and Exchange Commission.
Several other large investors also recently made changes to their positions in UNH. Advisor Partners LLC lifted its holdings in shares of UnitedHealth Group by 6.5% in the 4th quarter. Advisor Partners LLC now owns 31,893 shares of the healthcare conglomerate’s stock valued at $7,945,000 after buying an additional 1,949 shares during the period. TIAA CREF Investment Management LLC lifted its holdings in shares of UnitedHealth Group by 7.3% in the 3rd quarter. TIAA CREF Investment Management LLC now owns 5,462,680 shares of the healthcare conglomerate’s stock valued at $1,453,291,000 after buying an additional 370,179 shares during the period. Financial Enhancement Group LLC lifted its holdings in shares of UnitedHealth Group by 2,579.3% in the 3rd quarter. Financial Enhancement Group LLC now owns 1,554 shares of the healthcare conglomerate’s stock valued at $413,000 after buying an additional 1,496 shares during the period. Legacy Bridge LLC acquired a new position in shares of UnitedHealth Group in the 4th quarter valued at about $824,000. Finally, LS Investment Advisors LLC lifted its holdings in shares of UnitedHealth Group by 38.9% in the 4th quarter. LS Investment Advisors LLC now owns 34,921 shares of the healthcare conglomerate’s stock valued at $8,700,000 after buying an additional 9,784 shares during the period. Institutional investors and hedge funds own 86.68% of the company’s stock.
Shares of NYSE:UNH opened at $245.54 on Tuesday. The company has a market capitalization of $237.26 billion, a PE ratio of 19.06, a P/E/G ratio of 1.27 and a beta of 0.79. UnitedHealth Group Inc has a twelve month low of $214.63 and a twelve month high of $287.94. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.64.
The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 19th. Shareholders of record on Monday, March 11th were paid a $0.90 dividend. The ex-dividend date was Friday, March 8th. This represents a $3.60 annualized dividend and a yield of 1.47%. UnitedHealth Group’s dividend payout ratio is presently 27.95%.
In other news, Director William C. Ballard, Jr. sold 5,000 shares of the stock in a transaction on Tuesday, January 22nd. The shares were sold at an average price of $266.61, for a total value of $1,333,050.00. Following the completion of the transaction, the director now owns 77,702 shares in the company, valued at approximately $20,716,130.22. The sale was disclosed in a filing with the SEC, which is available at this link. Also, Director Gail R. Wilensky sold 2,930 shares of the stock in a transaction dated Thursday, March 14th. The stock was sold at an average price of $253.39, for a total transaction of $742,432.70. Following the sale, the director now owns 64,726 shares of the company’s stock, valued at approximately $16,400,921.14. The disclosure for this sale can be found here. In the last quarter, insiders sold 32,930 shares of company stock worth $8,495,383. Company insiders own 0.87% of the company’s stock.
UNH has been the subject of several analyst reports. Zacks Investment Research cut UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Tuesday, December 18th. Oppenheimer boosted their price objective on UnitedHealth Group from $300.00 to $305.00 and gave the company an “outperform” rating in a report on Wednesday, January 16th. Cleveland Research reissued a “buy” rating on shares of UnitedHealth Group in a report on Friday, January 11th. Argus boosted their price objective on UnitedHealth Group from $285.00 to $295.00 and gave the company a “buy” rating in a report on Monday, December 17th. Finally, Credit Suisse Group reissued a “buy” rating and issued a $310.00 price objective on shares of UnitedHealth Group in a report on Friday, February 8th. Three analysts have rated the stock with a hold rating and twenty have issued a buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and a consensus target price of $297.80.
ILLEGAL ACTIVITY NOTICE: “Mark Sheptoff Financial Planning LLC Grows Holdings in UnitedHealth Group Inc (UNH)” was published by Sports Perspectives and is the property of of Sports Perspectives. If you are reading this piece of content on another site, it was illegally stolen and republished in violation of U.S. & international copyright laws. The legal version of this piece of content can be viewed at https://sportsperspectives.com/2019/04/02/mark-sheptoff-financial-planning-llc-grows-holdings-in-unitedhealth-group-inc-unh.html.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Recommended Story: What is Net Asset Value (NAV)?
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.